Avalo Therapeutics (AVTX) Enterprise Value Growth (1y) (2015 - 2026)
Avalo Therapeutics (AVTX) Enterprise Value Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -92,080.65% |
| Dec 31, 2025 | 26.91% |
| Sep 30, 2025 | -3.53% |
| Mar 31, 2025 | -1,450.00% |
| Dec 31, 2024 | -1,714.51% |
| Sep 30, 2024 | -704.11% |
| Mar 31, 2024 | 99.98% |
| Dec 31, 2023 | -49,333.33% |
| Sep 30, 2023 | -19,107.55% |
| Jun 30, 2023 | -44,950.00% |
| Mar 31, 2023 | 56.62% |
| Dec 31, 2022 | 70.59% |
| Sep 30, 2022 | 67.68% |
| Jun 30, 2022 | 99.97% |
| Mar 31, 2022 | -0.46% |
| Dec 31, 2021 | -34.21% |
| Sep 30, 2021 | -24.24% |
| Jun 30, 2021 | 10.92% |
| Mar 31, 2021 | -159.19% |
| Dec 31, 2020 | 99.50% |